All lobbying filings

Checkmate Government Relations

Checkmate Government Relations filed a Q1 report for Regeneron Pharmaceuticals Inc. on April 15, 2026, reporting $90,000 in lobbying income.

Lobbying for Regeneron Pharmaceuticals Inc. · Pharmaceutical company

As filed: CHECKMATE GOVERNMENT RELATIONS for REGENERON PHARMACEUTICALS INC.

All filings by Checkmate Government Relations · Everything Regeneron Pharmaceuticals Inc. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 15, 2026

Income

$90,000

What the client paid this registrant for the period.

Client based in

New York

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

There is no current bill filed. Engagement with HHS regarding issues related to healthcare.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.